Company news
Anixa Biosciences, Inc. (NASDAQ:ANIX) news
Anixa Biosciences, Inc. news releases on 6ix. Latest, Jul 28, 2020: Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission
Press releases — page 4
Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission
July 27, 2020
Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders
July 19, 2020
Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds
July 5, 2020
Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline
July 1, 2020
Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate
May 3, 2020
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek™ Liquid Biopsy Technology
April 22, 2020
Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics
April 19, 2020
Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference
March 1, 2020
Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program
February 11, 2020
Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference
January 5, 2020
Anixa Biosciences Announces Commercial Launch of Cchek(TM) Prostate Cancer Confirmatory Test
December 15, 2019
Anixa Biosciences Provides Update on CAR-T Program
December 12, 2019
Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium
December 1, 2019
Anixa Biosciences Announces Genesis Research to Join Cchek(TM) Prostate Cancer Study
November 25, 2019
Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek(TM) Prostate Cancer Study
November 21, 2019
Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek(TM) Prostate Cancer Study
November 19, 2019
Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine
November 4, 2019
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
October 27, 2019
Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek(TM) Prostate Cancer Study
October 24, 2019
Anixa Biosciences Announces Abstract Accepted for Presentation at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019)
October 21, 2019
Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts
October 14, 2019
Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board
October 9, 2019
Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek(TM) Prostate Cancer Study
September 22, 2019
Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek(TM) Prostate Cancer Study
September 18, 2019
Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek(TM) Prostate Cancer Study
July 28, 2019
Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology
July 23, 2019
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology
July 16, 2019
Anixa Biosciences Announces Completion of Cchek(TM) Analytical Verification at CLIA Laboratory
May 12, 2019
Anixa Biosciences Extends and Expands its Collaboration with New Jersey Urology
April 10, 2019
Anixa Biosciences Presents Cchek(TM) Prostate Cancer Detection Data at AACR Annual Meeting
April 2, 2019